KDM3A controlled H3K9me1/2 ChIP-Seq data shows a strong enrichment of AR binding sites within the CWR22Rv1 castration-resistant prostate cancer cell line with continued expression of genes involved in the androgen response. This evidence concerns the gene KDM3A and Familial prostate cancer.